Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • hazard ratioRemove hazard ratio filter
    Clear all

    Article Type

    • Research Article5
    • Rapid Communication1

    Publication Date

    Author

    • Garbe, Claus2
    • Leiter, Ulrike2
    • Aitken, Joanne F1
    • Amos, Christopher I1
    • Baade, Peter D1
    • Bassett, Roland L1
    • Breuninger, Helmut1
    • Cormier, Janice N1
    • Dai, Wei1
    • Dang, Yifang1
    • Davies, Michael A1
    • Dusingize, Jean Claude1
    • Eigentler, Thomas K1
    • Eigentler, Thomas Kurt1
    • Fang, Shenying1
    • Fiedler, Eckhard1
    • Gagel, Andrew1
    • Gao, Tianwen1
    • Gassenmaier, Maximilian1
    • Ge, Rui1
    • Gershenwald, Jeffrey E1
    • Goebeler, Matthias1
    • Green, Adele C1
    • Green, Adèle C1
    • Grischke, Eva-Maria1

    Journal

    • Journal of Investigative Dermatology6

    Keyword

    • CI6
    • confidence interval6
    • HR6
    • melanoma-specific survival2
    • MSS2
    • OS2
    • overall survival2
    • AJCC1
    • American Joint Committee on Cancer1
    • BCC1
    • BMI1
    • C-reactive protein1
    • CLND1
    • CRP1
    • DFS1
    • DMFS1
    • IQR1
    • KC1
    • NMSC1
    • PNI1
    • SCC1
    • SLNB1
    • SNP1
    • TANS1

    Access Filter

    • Open Access

    Melanoma

    6 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Original Article Clinical Research
      Open Archive

      Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study

      Journal of Investigative Dermatology
      Vol. 137Issue 11p2309–2315Published online: July 20, 2017
      • Thomas K. Eigentler
      • Ulrike Leiter
      • Hans-Martin Häfner
      • Claus Garbe
      • Martin Röcken
      • Helmut Breuninger
      Cited in Scopus: 88
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Cutaneous squamous cell carcinoma (cSCC) is an increasing health burden in white populations. We prospectively assessed risk factors for tumor-specific and overall survival in 1,434 patients who underwent surgery for cSCC between January 24, 2005, and May 29, 2015. A total of 2,149 invasive cSCCs were analyzed. Univariate and multivariate survival analyses included tumor thickness, horizontal size, body site, histological differentiation, desmoplastic growth, history of multiple cSCCs, and immunosuppression.
        Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study
      • Original Article Melanocytes/Melanoma
        Open Archive

        Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry

        Journal of Investigative Dermatology
        Vol. 137Issue 12p2570–2577Published online: July 20, 2017
        • Maximilian Gassenmaier
        • Thomas Kurt Eigentler
        • Ulrike Keim
        • Matthias Goebeler
        • Eckhard Fiedler
        • Gerold Schuler
        • and others
        Cited in Scopus: 17
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          For more than a century the Halstedian hypothesis of contiguous metastasis from the primary tumor through the lymphatics to distant sites shaped lymph node surgery for melanoma. We challenge this dogma of serial metastatic dissemination. A single-center series of 2,299 patients with cutaneous metastatic melanoma was investigated to analyze overall survival and distant metastasis-free survival of stage IV patients with or without primary lymphatic metastasis. Results were then compared with those of 2,134 patients from three independent centers of the German Central Malignant Melanoma Registry.
          Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry
        • Letter to the Editor
          Open Archive

          Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes

          Journal of Investigative Dermatology
          Vol. 137Issue 8p1792–1795Published online: April 22, 2017
          • Shenying Fang
          • Yuling Wang
          • Yifang Dang
          • Andrew Gagel
          • Merrick I. Ross
          • Jeffrey E. Gershenwald
          • and others
          Cited in Scopus: 31
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Obesity is a known risk factor for cancer development (Arnold et al., 2016; Basen-Engquist and Chang, 2011; Renehan et al., 2015) and death (Calle et al., 2003). Obesity has been associated with an increased risk of developing melanoma in men (Sergentanis et al., 2013) and with thicker primary melanomas (Skowron et al., 2015). The inflammatory adipokine leptin promotes melanoma progression in mice (Amjadi et al., 2011; Brandon et al., 2009; Gogas et al., 2008); elevated leptin levels may predict melanoma sentinel node metastasis (Oba et al., 2016).
          • Original Article Epidemiology
            Open Archive

            Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma

            Journal of Investigative Dermatology
            Vol. 137Issue 8p1700–1708Published online: April 14, 2017
            • Jean Claude Dusingize
            • Catherine M. Olsen
            • Nirmala P. Pandeya
            • Padmini Subramaniam
            • Bridie S. Thompson
            • Rachel E. Neale
            • and others
            Cited in Scopus: 42
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Sunlight is the principal environmental risk factor for keratinocyte cancers, but other carcinogens have also been implicated, including tobacco smoke. Findings have been conflicting, however. We investigated associations between cigarette smoking and incidence of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) in QSkin, a prospective study of skin cancer (N = 43,794). Smoking history was self-reported at baseline; newly diagnosed BCCs and SCCs were ascertained through data linkage and verified by histopathology reports.
              Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma
            • Original Article Melanocytes/Melanoma
              Open Archive

              Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study

              Journal of Investigative Dermatology
              Vol. 136Issue 11p2270–2276Published online: March 23, 2016
              • Danny R. Youlden
              • Peter D. Baade
              • H. Peter Soyer
              • Philippa H. Youl
              • Michael G. Kimlin
              • Joanne F. Aitken
              • and others
              Cited in Scopus: 37
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                The prognosis of melanoma patients who are diagnosed with multiple primary lesions remains controversial. We used a large population-based cohort to re-examine this issue, applying a delayed entry methodology to avoid survival bias. Of 32,238 eligible patients diagnosed between 1995 and 2008, 29,908 (93%) had a single invasive melanoma, 2,075 (6%) had two, and 255 (1%) had three. Allowing for differences in entry time, 10-year cause-specific survival for these three groups was 89% (95% confidence interval [CI] = 88–90%), 83% (95% CI = 80–86%), and 67% (95% CI = 54–81%), respectively.
                Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study
              • Original Article Melanocytes/Melanoma
                Open Archive

                Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis

                Journal of Investigative Dermatology
                Vol. 136Issue 5p985–993Published online: January 29, 2016
                • Sen Guo
                • Weinan Guo
                • Shuli Li
                • Wei Dai
                • Nan Zhang
                • Tao Zhao
                • and others
                Cited in Scopus: 40
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  Melanoma is among the most malignant cancers with notorious aggressiveness, and its prognosis is greatly influenced by progression status. Serum microRNAs are small noncoding RNAs with high stability and easy accessibility in human blood. Their expression profiles are frequently dysregulated in cancers; hence, levels of serum microRNAs may reflect progression status and thus predict melanoma prognosis. In a hospital based case-control study, we found a significant reduction of serum miR-16 level in melanoma patients compared with cancer-free controls (P < 0.001).
                  Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis
                Page 1 of 1

                Login to your account

                Show
                Forgot password?
                Don’t have an account?
                Create a Free Account

                If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                Cancel
                • Home
                • Articles & Issues
                • Articles In Press
                • Current Issue
                • List of Issues
                • Meeting Abstracts
                • Supplements
                • Authors
                • About Open Access
                • Submit a Manuscript
                • Welcome, Authors!
                • Information for Authors
                • Information for Authors - PDF Download
                • Contact
                • Permissions
                • Reviewers
                • Information for Reviewers
                • Reviewer Login
                • Journal Info
                • About the Journal
                • About Open Access
                • Contact the Editorial Office
                • Editorial Board
                • Abstracting/Indexing
                • Access Instructions
                • New Content Alerts
                • Submit a Manuscript
                • Why Publish in JID?
                • Collections
                • Atopic Dermatitis
                • Cover Gallery
                • Itch
                • JAAD / JID Junction
                • Landmarks in Cutaneous Biology
                • Melanoma
                • Methods and Techniques for Skin Research
                • Montagna Symposium on the Biology of Skin
                • Pemphigus & Pemphigoid
                • Progress in Translational Research
                • Psoriasis
                • Resources for Clinical Research in the JID
                • News
                • Society/Journal News
                • Advertisers
                • SID
                • SID Member Activation
                • SID Website
                • Join SID
                • Annual Meeting
                • Academic Industry Partnership
                • ESDR
                • ESDR Website
                • Join ESDR
                • Awards
                • Events
                • Media
                • Education
                • JAAD / JID Junction - NEW!
                • Companion Titles
                • Journal of Investigative Dermatology Symposium Proceedings
                • JID Innovations
                • Follow Us
                • Facebook
                • Twitter

                The content on this site is intended for healthcare professionals.



                We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                • Privacy Policy  
                • Terms and Conditions  
                • Accessibility  
                • Help & Contact

                RELX